Skip to main content
  • Forums
  • Log in
  • Contact us
  • Policy
www.notifylibrary.org
  • The Notify Project
    • History
    • Who we are
    • Interviews
        1. Health authorities
        2. The Experts
    • Useful links
    • Global consultation reports
  • Search Library
    • Search tutorial
    • Adverse occurrence search
    • Reference search
    • Bibliographic list
        1. Authors
        2. Keywords
    • Add or update record
    • Editorial Group Tools
        1. MPHO taxonomy
        2. Adv. occurrence taxonomy
        3. Imputability table
        4. VIDEO TUTORIAL
    • Database content analysis
  • Notify Booklet
    • 1 INTRODUCTION
    • 2 THE V&S CHAIN FOR MPHOs
    • 3 VIGILANCE AND SURVEILLANCE: HISTORY AND BASIC ELEMENTS
    • 4 MEDICAL PRODUCTS OF HUMAN ORIGIN (MPHO) - DONATION AND ETHICS
    • ANNEX 1. Notify Library - MPHO type taxonomy
    • 5 TOWARDS A GLOBAL GOVERNANCE OF MPHO
    • 6 THE V&S SYSTEM IS PRIMARILY A RESPONSIBILITY FOR HEALTH AUTHORITIES
    • 7 ORGANIZATION FOR A COMPREHENSIVE - VIGILANCE & SURVEILLANCE SYSTEM
    • 8 VIGILANCE & SURVEILLANCE - RECOGNITION RELIES ON HEALTH CARE STAFF
    • 9 INVESTIGATING OCCURRENCES THAT COULD CAUSE HARM - LEARNING FROM ERRORS
    • 10 PROJECT NOTIFY
    • 11 THE NOTIFY DATABASE - LEARNING FROM VIGILANCE
    • 12 RISKS ASSOCIATED WITH LIVING DONATION
    • 13 HARM TO RECIPIENT - INFECTIONS
    • 14 HARM TO RECIPIENT - NON INFECTIOUS BLOOD TRANSFUSION REACTIONS
    • 15 HARM TO RECIPIENTS - MALIGNANCY
    • 16 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - HPC
    • 17 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - gamets and embryos
    • 18 CHARACTERISTICS, HANDLING AND CLINICAL ERRORS
    • 19 TRACEABILITY, AN ABSOLUTE PRE-REQUISITE FOR MPHO SAFETY
    • ANNEX 2. Notify Library - Adverse occurrence type taxonomy
    • REFERENCES
  • Background Documents
Home / Bibliography

Bibliography

Export 6 results:
Filters: Author is Friedlaender,G. E.  [Clear All Filters]
1999
Friedlaender GE, Strong DM, Tomford WW, Mankin HJ. Long-term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am. 1999;30(4):583-8.
1996
Strong DM, Friedlaender GE, Tomford WW, Springfield DS, Shives TC, Burchardt H, et al. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res. 1996;(326):107-14.
1984
Friedlaender GE, Strong DM, Sell KW. Studies on the antigenicity of bone. II. Donor-specific anti-HLA antibodies in human recipients of freeze-dried allografts. J Bone Joint Surg Am. 1984;66(1):107-12.
1983
Friedlaender GE. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res. 1983;(174):58-68.
1978
Friedlaender GE, Sell KW, Strong DM. Bone allograft antigenicity in an experimental model and in man. Acta Med Pol. 1978;19(40575):197-205.
1976
Friedlaender GE, Strong DM, Sell KW. Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits. J Bone Joint Surg Am. 1976;58(6):854-8.
↑
  • Forums
  • Log in
  • Contact us
  • Policy

Disclaimer

The cases, bibliography and associated comments included in this website and database have been provided by experts worldwide and reviewed by voluntary editorial working groups. The data and information is not guaranteed to be complete or to be fully up to date at any particular moment and it reflects the knowledge and views of the experts participating, not those of the World Health Organisation or the Italian National Transplant Centre.